Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986–95.
CAS
Article
PubMed
Google Scholar
McKie AT, Latunde-Dada GO, Miret S, et al. Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans. 2002;30:722–4.
CAS
Article
PubMed
Google Scholar
Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut. 2002;51:290–5.
CAS
Article
PubMed
PubMed Central
Google Scholar
Sargent PJ, Farnaud S, Evans RW. Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem. 2005;12:2683–93.
CAS
Article
PubMed
Google Scholar
Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277–87.
CAS
Article
PubMed
Google Scholar
Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739–61.
CAS
PubMed
Google Scholar
Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327–31.
CAS
Article
PubMed
Google Scholar
Ikuta K, Zak O, Aisen P. Recycling, degradation and sensitivity to the synergistic anion of transferrin in the receptor-independent route of iron uptake by human hepatoma (HuH–7) cells. Int J Biochem Cell Biol. 2004;36:340–52.
CAS
Article
PubMed
Google Scholar
Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA. 2006;103:13612–7.
CAS
Article
PubMed
PubMed Central
Google Scholar
Schranzhofer M, Schifrer M, Cabrera JA, et al. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood. 2006;107:4159–67.
CAS
Article
PubMed
Google Scholar
Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol. 2002;39:270–81.
CAS
Article
PubMed
Google Scholar
Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–10.
CAS
Article
PubMed
Google Scholar
Inamura J, Ikuta K, Jimbo J, et al. Upregulation of hepcidin by interleukin-1beta in human hepatoma cell lines. Hepatol Res. 2005;33:198–205.
CAS
Article
PubMed
Google Scholar
Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol. 2004;11:251–4.
CAS
Article
PubMed
Google Scholar
Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669–73.
CAS
Article
PubMed
Google Scholar
Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology. 2007;46:1291–301.
CAS
Article
PubMed
Google Scholar
Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109:5027–35.
CAS
Article
PubMed
PubMed Central
Google Scholar
Cazzola M, Huebers HA, Sayers MH, MacPhail AP, Eng M, Finch CA. Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood. 1985;66:935–9.
CAS
PubMed
Google Scholar
Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23:185–92.
CAS
Article
PubMed
Google Scholar
Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem. 2007;113:30–54.
CAS
Article
PubMed
Google Scholar
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161–203.
Article
PubMed
Google Scholar
Jacobs A, Beamish MR, Allison M. The measurement of circulating ferritin. J Clin Pathol. 1972;25:1003.
CAS
Article
PubMed
PubMed Central
Google Scholar
Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4:206–8.
CAS
Article
PubMed
PubMed Central
Google Scholar
Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447–55.
CAS
PubMed
Google Scholar
Saito H, Hayashi D, Ohya T, Ohya F, Yamada H. Clinical evaluation on serum ferritin (author’s transl). Rinsho Ketsueki. 1979;20:1317–25.
CAS
PubMed
Google Scholar
Galanello R, Piga A, Forni GL, et al. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in paediatric patients with β-thalassaemia major. Haematologica. 2006;91:1343–51.
CAS
PubMed
Google Scholar
Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–62.
CAS
Article
PubMed
Google Scholar
Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003;101:4632–9.
CAS
Article
PubMed
Google Scholar
Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol. 2007;78:487–94.
CAS
Article
PubMed
Google Scholar
Gattermann N. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Leuk Res. 2007;31(Suppl 3):S10–5.
CAS
Article
PubMed
Google Scholar
Olivieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med. 1995;332:918–22.
CAS
Article
PubMed
Google Scholar
Long JA Jr, Doppman JL, Nienhus AW, Mills SR. Computed tomographic analysis of beta-thalassemic syndromes with hemochromatosis: pathologic findings with clinical and laboratory correlations. J Comput Assist Tomogr. 1980;4:159–65.
Article
Google Scholar
Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982;307:1671–5.
CAS
Article
PubMed
Google Scholar
Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127:348–55.
CAS
Article
PubMed
Google Scholar
Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem. 2002;91:9–18.
CAS
Article
PubMed
Google Scholar
Yen AW, Fancher TL, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med. 2006;119:391–9.
CAS
Article
PubMed
Google Scholar
Pietrangelo A. Hereditary hemochromatosis—a new look at an old disease. N Engl J Med. 2004;350:2383–97.
CAS
Article
PubMed
Google Scholar
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.
CAS
Article
PubMed
Google Scholar
Franchini M. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol. 2006;81:202–9.
CAS
Article
PubMed
Google Scholar
Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003;30:137–44.
CAS
Article
PubMed
Google Scholar
Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27–30.
CAS
Article
PubMed
Google Scholar
McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J. 2003;146:388–97.
Article
PubMed
Google Scholar
Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.
CAS
Article
PubMed
Google Scholar
Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971–7.
CAS
Article
PubMed
Google Scholar
Olivieri NF. The β-thalassemias. N Engl J Med. 1999;341:99–109.
CAS
Article
PubMed
Google Scholar
Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135:574–82.
Article
PubMed
Google Scholar